Cargando…

Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study

OBJECTIVES: To evaluate, in a multicentric Italian cohort of axial spondyloarthritis (axSpA) patients on Secukinumab (SEC) followed for 24 months: (1) the long-term effectiveness and safety of SEC; (2) the drug retention rate and low disease activity (LDA) measured as Bath Ankylosing Spondylitis Dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramonda, Roberta, Lorenzin, Mariagrazia, Sole Chimenti, Maria, D’Angelo, Salvatore, Marchesoni, Antonio, Salvarani, Carlo, Lubrano, Ennio, Costa, Luisa, Dal Bosco, Ylenia, Fracassi, Elena, Ortolan, Augusta, Ferraioli, Mario, Carriero, Antonio, Visalli, Elisa, Bixio, Riccardo, Desiati, Francesca, Bergamini, Alberto, Pedrollo, Elisa, Doria, Andrea, Foti, Rosario, Carletto, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058366/ https://www.ncbi.nlm.nih.gov/pubmed/35510168 http://dx.doi.org/10.1177/1759720X221090310

Ejemplares similares

Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study
por: Ramonda, Roberta, et al.
Publicado: (2021)

The Genetic Contribution to Drug Response in Spondyloarthritis: A Systematic Literature Review
por: Ortolan, Augusta, et al.
Publicado: (2021)

An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision
por: Lorenzin, Mariagrazia, et al.
Publicado: (2020)

Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study
por: Lubrano, Ennio, et al.
Publicado: (2020)

SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology
por: Ortolan, Augusta, et al.
Publicado: (2021)

Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study
por: D'Angelo, Salvatore, et al.
Publicado: (2019)

Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: an observational study from the SPACE cohort
por: de Hooge, Manouk, et al.
Publicado: (2016)

Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options
por: Bixio, Riccardo, et al.
Publicado: (2022)

Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort
por: Ometto, Francesca, et al.
Publicado: (2021)

Correction to: Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort
por: Ometto, Francesca, et al.
Publicado: (2021)

Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study)
por: Lorenzin, Mariagrazia, et al.
Publicado: (2019)

Residual Disease in Patients with Axial Spondyloarthritis: A Post-Hoc Analysis of the QUASAR Study †
por: D’Angelo, Salvatore, et al.
Publicado: (2022)

Spine and Sacroiliac Joints Lesions on Magnetic Resonance Imaging in Early Axial-Spondyloarthritis During 24-Months Follow-Up (Italian Arm of SPACE Study)
por: Lorenzin, Mariagrazia, et al.
Publicado: (2020)

Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis
por: Ortolan, Augusta, et al.
Publicado: (2020)

Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
por: Lorenzin, Mariagrazia, et al.
Publicado: (2015)

Validation of the Italian Version of the Educational Needs Assessment Tool in Rheumatoid Arthritis Patients and Factors Associated with Educational Needs
por: Favero, Marta, et al.
Publicado: (2020)

Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort
por: Ortolan, Augusta, et al.
Publicado: (2018)

Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement
por: Chimenti, Maria Sole, et al.
Publicado: (2021)

Sex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients
por: Chimenti, Maria-Sole, et al.
Publicado: (2021)

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
por: Alonso, Sara, et al.
Publicado: (2021)

Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis
por: Gentileschi, Stefano, et al.
Publicado: (2020)

Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey
por: Ramonda, Roberta, et al.
Publicado: (2016)

Fetuin-A: A Novel Biomarker of Bone Damage in Early Axial Spondyloarthritis. Results of an Interim Analysis of the SPACE Study
por: Favero, Marta, et al.
Publicado: (2023)

Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study
por: Lorenzin, Mariagrazia, et al.
Publicado: (2021)

Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease
por: Rizzello, Fernando, et al.
Publicado: (2018)

Changes in bone turnover markers and bone modulators during abatacept treatment
por: Adami, Giovanni, et al.
Publicado: (2023)

Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence
por: Braun, Jürgen, et al.
Publicado: (2021)

Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum
por: Sivera, Francisca, et al.
Publicado: (2023)

Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases
por: Tosato, Sarah, et al.
Publicado: (2022)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
por: Lubrano, Ennio, et al.
Publicado: (2016)

Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
por: Atzeni, Fabiola, et al.
Publicado: (2021)

Telemedicine in the Management of Patients with Rheumatic Disease during COVID-19 Pandemic: Incidence of Psychiatric Disorders and Fibromyalgia in Patients with Rheumatoid Arthritis and Psoriatic Arthritis
por: Foti, Rosario, et al.
Publicado: (2022)

Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study
por: Venerito, Vincenzo, et al.
Publicado: (2023)

Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
por: Sun, Yuankai, et al.
Publicado: (2022)

New Insights in Physical Therapy and Rehabilitation in Axial Spondyloarthritis: A Review
por: Perrotta, Fabio Massimo, et al.
Publicado: (2019)

Genetics, Epigenetics, and Gender Impact in Axial-Spondyloarthritis Susceptibility: An Update on Genetic Polymorphisms and Their Sex Related Associations
por: Chimenti, Maria Sole, et al.
Publicado: (2021)

Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFα therapy
por: Aita, Ada, et al.
Publicado: (2018)

Erythrodermic psoriasis and palmoplantar hyperkeratosis successfully treated with secukinumab: a case report
por: Carriero, Martino
Publicado: (2022)

Incidence of Disease Flare After BNT162b2 Coronavirus Disease 2019 Vaccination in Patients With Rheumatoid Arthritis in Remission
por: Bixio, Riccardo, et al.
Publicado: (2021)

Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
por: Aparicio, María, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tmu2f76d295afvdp2crhc1pvbk